Drug Shortage Report for GD-AMLODIPINE/ATORVASTATIN
Report ID | 16832 |
Drug Identification Number | 02362759 |
Brand name | GD-AMLODIPINE/ATORVASTATIN |
Common or Proper name | GD-Amlodipine/Atorvastatin |
Company Name | UPJOHN CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE ATORVASTATIN |
Strength(s) | 5MG 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90s |
ATC code | C10BX |
ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-07-19 |
Actual start date | |
Estimated end date | 2017-08-03 |
Actual end date | 2017-08-03 |
Shortage status | Resolved |
Updated date | 2017-08-04 |
Company comments | Resolved August 3, 2017 |
Health Canada comments | |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.